United States · FDA National Drug Code directory
Fludarabine phosphate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45963-609_6ee71a09-01b9-4412-9048-a8ed9b6b0051
- Product NDC
- 45963-609
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Fludarabine phosphate
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150105
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUDARABINE PHOSPHATE — 50 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (45963-609-55) / 2 mL in 1 VIAL, GLASS · 45963-609-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →